These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 9566927

  • 1. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage.
    Paulson TG, Almasan A, Brody LL, Wahl GM.
    Mol Cell Biol; 1998 May; 18(5):3089-100. PubMed ID: 9566927
    [Abstract] [Full Text] [Related]

  • 2. Inefficient growth arrest in response to dNTP starvation stimulates gene amplification through bridge-breakage-fusion cycles.
    Poupon MF, Smith KA, Chernova OB, Gilbert C, Stark GR.
    Mol Biol Cell; 1996 Mar; 7(3):345-54. PubMed ID: 8868464
    [Abstract] [Full Text] [Related]

  • 3. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.
    Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR.
    Mol Cell Biol; 1998 Jan; 18(1):536-45. PubMed ID: 9418900
    [Abstract] [Full Text] [Related]

  • 4. p53-dependent growth arrest of REF52 cells containing newly amplified DNA.
    Ishizaka Y, Chernov MV, Burns CM, Stark GR.
    Proc Natl Acad Sci U S A; 1995 Apr 11; 92(8):3224-8. PubMed ID: 7724543
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A, Fan H, Taylor WR, Wright JA.
    Cancer Res; 1997 Nov 01; 57(21):4876-81. PubMed ID: 9354452
    [Abstract] [Full Text] [Related]

  • 7. Drug resistance in KHT fibrosarcoma cell lines with different metastatic ability.
    Cillo C, Ling V, Hill RP.
    Int J Cancer; 1989 Jan 15; 43(1):107-11. PubMed ID: 2910823
    [Abstract] [Full Text] [Related]

  • 8. Phenotypic resistance to methotrexate and N-phosphonacetyl L-aspartate is induced by treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Kinsella AR, Fox M.
    Int J Cancer; 1988 Jul 15; 42(1):87-93. PubMed ID: 3391708
    [Abstract] [Full Text] [Related]

  • 9. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
    Huang A, Wright JA.
    Oncogene; 1994 Feb 15; 9(2):491-9. PubMed ID: 7904743
    [Abstract] [Full Text] [Related]

  • 10. Properties of single-step mutants of Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
    Zieg J, Clayton CE, Ardeshir F, Giulotto E, Swyryd EA, Stark GR.
    Mol Cell Biol; 1983 Nov 15; 3(11):2089-98. PubMed ID: 6656764
    [Abstract] [Full Text] [Related]

  • 11. The presence of amplified regions affects the stability of chromosomes in drug-resistant Chinese hamster cells.
    Miele M, Bonatti S, Menichini P, Ottaggio L, Abbondandolo A.
    Mutat Res; 1989 May 15; 219(3):171-8. PubMed ID: 2567961
    [Abstract] [Full Text] [Related]

  • 12. Hamster cells with increased rates of DNA amplification, a new phenotype.
    Giulotto E, Knights C, Stark GR.
    Cell; 1987 Mar 13; 48(5):837-45. PubMed ID: 3815526
    [Abstract] [Full Text] [Related]

  • 13. Protein alterations associated with gene amplification in cultured human and rodent cells.
    Conner EA, Wirth PJ.
    Electrophoresis; 1996 Jul 13; 17(7):1257-64. PubMed ID: 8855414
    [Abstract] [Full Text] [Related]

  • 14. Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins.
    El-Hizawi S, Lagowski JP, Kulesz-Martin M, Albor A.
    Cancer Res; 2002 Jun 01; 62(11):3264-70. PubMed ID: 12036943
    [Abstract] [Full Text] [Related]

  • 15. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells.
    Wahl GM, Padgett RA, Stark GR.
    J Biol Chem; 1979 Sep 10; 254(17):8679-89. PubMed ID: 381311
    [Abstract] [Full Text] [Related]

  • 16. Geminin functions downstream of p53 in K-ras-induced gene amplification of dihydrofolate reductase.
    Shen L, Nishioka T, Guo J, Chen C.
    Cancer Res; 2012 Dec 01; 72(23):6153-62. PubMed ID: 23026135
    [Abstract] [Full Text] [Related]

  • 17. Structure of amplified DNA in different Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
    Ardeshir F, Giulotto E, Zieg J, Brison O, Liao WS, Stark GR.
    Mol Cell Biol; 1983 Nov 01; 3(11):2076-88. PubMed ID: 6656763
    [Abstract] [Full Text] [Related]

  • 18. The propensity for gene amplification: a comparison of protocols, cell lines, and selection agents.
    Sharma RC, Schimke RT.
    Mutat Res; 1994 Jan 16; 304(2):243-60. PubMed ID: 7506368
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.